Addex Therapeutics Ltd (ADXN) Q4 2025 Earnings Call Transcript

April 30, 2026 05:11:34 pm

Source: SeekingAlpha

2026-04-30 17:11:34 ET

Addex Therapeutics Ltd (ADXN) Q4 2025 Earnings Call April 30, 2026 10:00 AM EDT

Company Participants

Timothy Dyer - Co-Founder, CEO & Director
Mikhail Kalinichev - Head of Translational Science
...

For further details see:

Addex Therapeutics Ltd

0.0% G/L:

$6.70 Last:

169 Volume:

$6.70 Open:

September 29, 2025 07:00:29 am

September 29, 2025 05:30:44 am

September 12, 2025 01:30:22 pm

June 19, 2025 12:04:00 pm

Market Cap $12,125,314

Float 1,320,996

Insiders Ownership N/A

Institutions 13

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country CH

City Geneva